Short-term mortality is not reduced with early administration of intravenous magnesium in high-risk patients having an acute myocardial infarction (MI). There is no reason to give intravenous magnesium unless patients have other indications for repletion, such as a low magnesium level or arrhythmia responsive to magnesium therapy